Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C4894 Thioetheramide-PCSummary: competitive, reversible inhibitor of secretory phospholipase A2 (sPLA2)
-
C5169 EA4Summary: rPLA2 inhibitor
-
C5346 MJ33 (lithium salt)Summary: inhibitor of the acidic, calcium-independent (ai)PLA2 activity of Prdx6
-
C5625 ONO-RS-082Summary: reversible inhibitor of Ca2+-independent phospholipase A2
-
C5678 ST638Summary: tyrosine kinase inhibitor and PLD inhibitor
-
B5448 CP 316819Summary: Selective glycogen phosphorylase inhibitor
-
B5503 GPi 688Summary: glycogen phosphorylase inhibitor
-
B5754 ML 298 hydrochlorideSummary: phospholipase D2 (PLD2) inhibitor
-
B4932 JJKK 048Summary: monoacylglycerol lipase (MAGL) inhibitor
-
B4933 ML 348Summary: lysophospholipase 1 (LYPLA1) inhibitor